FEB 05, 2015 9:00 AM PST

Keynote: Advances in Perioperative Care -Promoting good animal welfare and good science

C.E. Credits: CE
Speaker
  • Professor/Director, Comparative Biology Centre, The Medical School, University of Newcastle
    Biography
      Paul Flecknell qualified from Cambridge Veterinary School in 1976. He completed his PhD at the University of London, and is a Diplomat of the European Colleges of Veterinary Anesthesia and Analgesia and Laboratory Animal Medicine. He is an honorary Diplomat of the American College of Laboratory Animal medicine, and an honorary Fellow of the Royal College of Veterinary. Recently he was awarded an honorary doctorate by the University of Ghent. He is currently Director of the Comparative Biology Center at the University of Newcastle and is Professor of Laboratory Animal Science in the Institute of Neuroscience. His main research interests are anesthesia and analgesia of all species of animals and in particular the development of methods of pain assessment. He is the head of the Pain and Animal Welfare Science (PAWS) group at Newcastle, which involves the work of 9 academic staff and research students. The group have published over a 100 scientific papers, reviews and book chapters in the field of analgesia and anesthesia of laboratory animals. Current work is focused on novel methods of cage-side assessment of pain, particularly using pain faces and developing methods of measurement of effective state in rodents. His hobbies are bird-watching, photography, hiking and computer gaming.
      <br />

    Abstract

    Recent advances in anesthesia, monitoring, pain assessment and analgesia provide many opportunities for improving the quality of our in vivo scientific data, and promoting high standards of animal welfare. The appropriate use of electronic monitoring, and the importance of more basic supportive measures during anesthesia will be described. This will provide participants with a framework for evaluating the appropriate use of these techniques. New methods of assessing pain give us the opportunity to use analgesic agents more appropriately. They also give us new insight into the likely efficacy of particular analgesic agents. This section of the presentation will update participants on the application of cage-side assessments of pain, and provide a better understanding of the appropriate use of analgesics.

    Learning Objectives:

    1) To provide participants with a framework for evaluating the appropriate use of monitoring methods.
    2) To update participants on the application of cage-side assessments of pain, and provide a better understanding of the appropriate use of analgesics.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources
    Attendees
    • See more